Intervention Protocol

Botulinum toxin type A formulations in focal dystonias

  1. João Costa*,
  2. Joaquim Ferreira,
  3. Rita Freire,
  4. Miguel M Coelho,
  5. Cristina Sampaio

Editorial Group: Cochrane Movement Disorders Group

Published Online: 26 JAN 2004

DOI: 10.1002/14651858.CD004313.pub2


How to Cite

Costa J, Ferreira J, Freire R, Coelho MM, Sampaio C. Botulinum toxin type A formulations in focal dystonias (Protocol). Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD004313. DOI: 10.1002/14651858.CD004313.pub2.

Author Information

  1. Faculdade de Medicina de Lisboa, Laboratório de Farmacologia Clínica e Terapêutica, Lisboa, Portugal

*João Costa, Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, Lisboa, 1649-028, Portugal. joaoncosta@sapo.pt.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 26 JAN 2004

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the clinical efficacy, safety and immunogenicity of Botulinum Toxin Type A formulations (Dysport® and Botox®) in the treatment of focal dystonias.